Exercise Program for Endometrial Cancer Survivors
Trial Summary
Do I need to stop taking my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using semaglutide (a type of diabetes medication) or have used hormone replacement therapy in the last 3 months.
What data supports the effectiveness of this treatment for endometrial cancer survivors?
Is the exercise program safe for endometrial cancer survivors?
How does the 12-week home-based exercise treatment for endometrial cancer survivors differ from other treatments?
This treatment is unique because it is a home-based exercise program specifically designed for endometrial cancer survivors, focusing on improving quality of life and physical fitness without the need for a gym or medical facility. Unlike traditional treatments that may involve medication or surgery, this program emphasizes physical activity as a way to enhance overall health and well-being.12478
What is the purpose of this trial?
STRIVE Cardio is a 12-week exercise intervention study with the goal to improve functional fitness and cardiovascular health for women who have completed treatment for non-metastatic endometrial cancer within the last five years and are currently in remission. Measures will include a functional fitness test, carotid-femoral pulse wave velocity, brachial artery flow mediated dilation, and a blood draw. Participants will be provided resistance bands, a dumbbell, and a Fitbit to keep. Participants will be compensated $50 for each of their two in-person visits.
Research Team
Jess Gorzelitz, PHD, MS
Principal Investigator
University of Iowa
Eligibility Criteria
The STRIVE Cardio trial is for English-speaking women aged 18-74 who have been treated for non-metastatic Type I endometrial cancer stages I-IIIc within the last five years and are now in remission. They must be able to use technology for telecoaching, pass a physical activity readiness test, get medical clearance if needed, and commit to the study's duration.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-Intervention
Participants wear an accelerometer for one week prior to the exercise intervention
Exercise Intervention
Participants engage in a 12-week distance-based exercise program with virtual health coaching and in-person pre- and post-intervention measures
Follow-up
Participants are monitored for changes in vascular structure and function, and other health metrics post-intervention
Treatment Details
Interventions
- 12-week home-based exercise intervention
12-week home-based exercise intervention is already approved in United States for the following indications:
- Improvement of functional fitness and cardiovascular health in endometrial cancer survivors
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jess S. Gorzelitz
Lead Sponsor